Feb 26 (Reuters) - Clayton Dubilier & Rice LLC has amassed $6.25 billion for its latest flagship private equity fund after it got oversubscribed, turning down as much as $2 billion from investors, ...

“(CD&R is) one of the largest private equity firms in the world and one of the most successful in terms of returns,” said Presidio CEO Bob Cagnazzi. “They are really smart, detailed and analytical.” ...

Clayton Dubilier & Rice made it a condition for banks to commit more than €1 billion ($1.1 billion) of debt to fund a part of the equity check for its bid for Sanofi’s consumer-health division, though ...

(Reuters) - U.S. private equity firm Clayton Dubilier & Rice (CD&R) said on Tuesday it had agreed to acquire a majority ownership position in information technology provider Presidio from UK-based BC ...

Sanofi and CD&R enter exclusive talks to sell a 50% stake in Opella, Sanofi's consumer health unit, valued at $17.4 billion. Opella serves over 500M consumers globally with top brands like Allegra and ...

Last week, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be ...

Clayton Dubilier & Rice is discussing the possibility of using borrowed money to fund a part of the equity check in its bid for Sanofi’s €15 billion ($16.6 billion) consumer health division, according ...